Fixed-Effect Parameter-Odds Ratio OR (95% CI)
p-value
Random-Effect Parameter-Standard deviation (95% CI)
p-value
Model A Model A Model A Model A
Individual center 0.66 (0.56 - 0.78) <0.001
Model B Model B Model B Model B
Individual center 0.68 (0.57 - 0.79) <0.001
Age 0.98 (0.97 – 0.98) <0.001
Gender Female (Yes/No) 1.36 (1.24 – 1.50) <0.001
Transplant year 0.95 (0.93 – 0.97) <0.001
Heart failure diagnosis Dilated as reference
Ischemic Cardiomyopathy 1.13 (1.02 – 1.25) 0.01
Congenital 1.01 (0.78 – 1.32) 0.88
Restrictive 1.04 (0.69 – 1.46) 0.94
Hypertrophied 0.91 (0.69 – 1.20) 0.51
Valvular 0.89 (0.69 – 1.14) 0.37
African American (Yes/No) 1.04 (0.94 – 1.16 0.40
PRA Class II >20% 1.12 (0.90-1.40) 0.29
HLA mismatch, 3 or more (Yes/No) 1.23 (1.09 – 1.39) 0.001
Donor:Recipient weight ratio 0.80 (0.67 – 0.96) 0.02
Donor age 0.99 (0.99-1.01) 0.20
Average transplant per year 1.00 (0.99 – 1.01) 0.80
Model C Model C Model C Model C
Individual center 0.67 (0.57 - 0.79) <0.001
Age 0.98 (0.97 – 0.98) <0.001
Gender Female (Yes/No) 1.36 (1.24 – 1.50) <0.001
Transplant year 0.95 (0.93 – 0.97) <0.001
Heart failure diagnosis Dilated as reference
Ischemic Cardiomyopathy 1.13 (1.02 – 1.25) 0.01
Congenital 1.02 (0.78 – 1.32) 0.87
Restrictive 1.01 (0.70 – 1.48) 0.91
Hypertrophied 0.91 (0.69 – 1.20) 0.53
Valvular 0.89 (0.69 – 1.14) 0.37
African American (Yes/No) 1.04 (0.94 – 1.16 0.39
HLA mismatch, > 3 (Yes/No) 1.23 (1.01 – 1.39) 0.001
Donor:Recipient weight ratio 0.79 (0.66 – 0.95) 0.01
Average transplant per year 1.00 (0.99 – 1.01) 0.79
Induction Therapy 0.93 (0.83 – 1.03) 0.20